GovTribe
Contact sales
Try for free
Login
Contact sales
Try for free
All Federal Grant Programs
Medicare Access and CHIP Reauthorization Act (MACRA) Funding Opportunity: Measure Development for the Quality Payment Program
Posted
9/10/18
Assistance Listing Number
93.986
Overview
Grant Opportunities
1
Grant Awards
7
Federal Agency
Centers for Medicare and Medicaid Services
Applicant Types
Not listed
Beneficiary Types
Not listed
Additional Information
Not listed
Popular Federal Grant Opportunities
Not listed
Popular Federal Grant Awards
Not listed
Name
Description
Awardee
Assistance Type
Dollars Obligated
(Click to sort descending)
Award Date
(Click to sort descending)
Updated At
(Click to sort descending)
1V1CMS331641
MEASURE DEVELOPMENT FOR QUALITY PAYMENT PROGRAM
Purchaser Business Group On Health
Cooperative Agreement
$2.8m
9/14/18
3/31/22
1V1CMS331636
MEDICARE ACCESS AND CHIP REAUTHORIZATION ACT OF 2015 (MACRA) FUNDING OPPORTUNITY: MEASURE DEVELOPMENT FOR THE QUALITY PAYMENT PROGRAM: CONTINUITY OF PHARMACOTHERAPY FOR OPIOID USE DISORDER
University Of Southern California
Cooperative Agreement
$443.7k
9/14/18
4/12/21
1V1CMS331637
MEASURING ORTHOPEDIC OUTCOMES ROUTINELY (MOOR)
Brigham & Womens Hospital Inc.
Cooperative Agreement
$5.7m
9/14/18
9/12/22
1V1CMS331640
MEDICARE ACCESS AND CHIP REAUTHORIZATION ACT OF 2015 (MACRA) FUNDING OPPORTUNITY: MEASURE DEVELOPMENT FOR THE QUALITY PAYMENT PROGRAM (MENTAL HEALTH/SUBSTANCE USE CARE)
American Psychiatric Association
Cooperative Agreement
$3.3m
9/14/18
3/30/22
1V1CMS331635
MEDICARE ACCESS AND CHIP REAUTHORIZATION ACT OF 2015 (MACRA) FUNDING OPPORTUNITY: MEASURE DEVELOPMENT FOR THE QUALITY PAYMENT PROGRAM
American Society For Clinical Pathology
Cooperative Agreement
$1.9m
9/14/18
3/30/22
Name
Description
Solicitation Number
Federal Agency
Due Date
(Click to sort descending)
Posted Date
(Click to sort descending)
Measure Development for the Quality Payment Program
The purpose of this Funding Opportunity is to provide funding assistance in the form of cooperative agreements to entities to develop, improve, update, or expand quality measures for use in the Quality Payment Program. Recognizing the benefits of measure development by external stakeholders with specific knowledge of clinician and patient perspectives and needs, the funding assistance of these cooperative agreements is specifically designated for entities external both to CMS and to other federal agencies. Such entities may include, but are not limited to, clinical specialty societies, clinical professional organizations, patient advocacy organizations, educational institutions, independent research organizations, health systems, and other entities engaged in quality measure development. These external entities provide the needed medical specialty and patient perspectives to lead or support the measure development priorities of the CMS Quality Measure Development Plan and, accordingly, to advance the Quality Payment Program measure portfolio. Specifically, collaboration with and support for these entities in measure development will assist CMS in addressing such essential topics as: clinician engagement, consumer-informed decisions, critical measure gaps, quality measure alignment, and efficient data collection that minimizes health care provider burden.
CMS-1V1-18-002
Department of Health and Human Services
6/5/18
3/2/18